Copyright
©The Author(s) 2003.
World J Gastroenterol. Jun 15, 2003; 9(6): 1374-1376
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1374
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1374
Figure 1 The overall survival rates for clinical T1-2 esophageal carcinoma treated with LCAF radiotherapy.
- Citation: Zhao KL, Wang Y, Shi XH. Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma. World J Gastroenterol 2003; 9(6): 1374-1376
- URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1374.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1374